• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

EZH2 inhibition for epithelioid sarcoma and follicular lymphoma.

作者信息

Groisberg Roman, Subbiah Vivek

机构信息

Department of Melanoma and Sarcoma Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.

Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, the University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

出版信息

Lancet Oncol. 2020 Nov;21(11):1388-1390. doi: 10.1016/S1470-2045(20)30530-1. Epub 2020 Oct 6.

DOI:10.1016/S1470-2045(20)30530-1
PMID:33035458
Abstract
摘要

相似文献

1
EZH2 inhibition for epithelioid sarcoma and follicular lymphoma.EZH2抑制用于上皮样肉瘤和滤泡性淋巴瘤。
Lancet Oncol. 2020 Nov;21(11):1388-1390. doi: 10.1016/S1470-2045(20)30530-1. Epub 2020 Oct 6.
2
Epigenetic Therapy for Epithelioid Sarcoma.上皮样肉瘤的表观遗传学治疗。
Cell. 2020 Apr 16;181(2):211. doi: 10.1016/j.cell.2020.03.042.
3
Targeting epigenetics in sarcomas through EZH2 inhibition.通过抑制 EZH2 靶向肉瘤中的表观遗传学。
J Hematol Oncol. 2020 Apr 7;13(1):33. doi: 10.1186/s13045-020-00868-4.
4
[INHIBITORY EZH2 NOWĄ OPCJĄ TERAPEUTYCZNĄ W LECZENIU NAWROTOWEGO LUB OPORNEGO CHŁONIAKA GRUDKOWEGO EZH2 INHIBITORS AS A NEW THERAPEUTIC OPTION FOR THE TREATMENT OF RELAPSED OR RECURRENT FOLLICULAR LYMPHOMA].EZH2抑制剂作为治疗复发性或难治性滤泡性淋巴瘤的一种新的治疗选择
Wiad Lek. 2018;71(5):1095-1098.
5
Emerging EZH2 Inhibitors and Their Application in Lymphoma.新型EZH2抑制剂及其在淋巴瘤中的应用
Curr Hematol Malig Rep. 2018 Oct;13(5):369-382. doi: 10.1007/s11899-018-0466-6.
6
EZH2 inhibition by tazemetostat: mechanisms of action, safety and efficacy in relapsed/refractory follicular lymphoma.塔西美坦抑制 EZH2：在复发/难治性滤泡性淋巴瘤中的作用机制、安全性和疗效。
Future Oncol. 2021 Jun;17(17):2127-2140. doi: 10.2217/fon-2020-1244. Epub 2021 Mar 12.
7
Tazemetostat: a treatment option for relapsed/refractory follicular lymphoma.他替莫唑胺：复发/难治性滤泡性淋巴瘤的治疗选择。
Expert Opin Pharmacother. 2022 Feb;23(3):295-301. doi: 10.1080/14656566.2021.2014815. Epub 2021 Dec 14.
8
Tazemetostat: First Approval.他泽莫司他：美国首次批准
Drugs. 2020 Apr;80(5):513-521. doi: 10.1007/s40265-020-01288-x.
9
Refining the management of relapsed or refractory follicular lymphoma.优化复发或难治性滤泡性淋巴瘤的治疗管理。
Clin Adv Hematol Oncol. 2020 Dec;18 Suppl 20(12):1-24.
10
Tazemetostat for advanced epithelioid sarcoma: current status and future perspectives.他米巴罗汀治疗高级别上皮样肉瘤：现状与未来展望。
Future Oncol. 2021 Apr;17(10):1253-1263. doi: 10.2217/fon-2020-0781. Epub 2020 Dec 8.

引用本文的文献

1
Safety and efficacy of HH2853, a novel EZH1/2 dual inhibitor, in patients with refractory solid tumours or non-Hodgkin lymphomas: a phase I study.新型EZH1/2双重抑制剂HH2853在难治性实体瘤或非霍奇金淋巴瘤患者中的安全性和有效性：一项I期研究
EClinicalMedicine. 2025 Aug 7;86:103398. doi: 10.1016/j.eclinm.2025.103398. eCollection 2025 Aug.
2
Prostate cancer epigenetics - from pathophysiology to clinical application.前列腺癌表观遗传学——从病理生理学到临床应用
Nat Rev Urol. 2025 Jan 16. doi: 10.1038/s41585-024-00991-8.
3
The oncogenic role of the NSD histone methyltransferases in head and neck and cervical cancers.
NSD组蛋白甲基转移酶在头颈癌和宫颈癌中的致癌作用。
Tumour Virus Res. 2024 Dec 5;19:200301. doi: 10.1016/j.tvr.2024.200301.
4
EZH2-Mediated H3K27 Trimethylation in the Liver of Mice Is an Early Epigenetic Event Induced by High-Fat Diet Exposure.高脂肪饮食暴露诱导的小鼠肝脏中 EZH2 介导的 H3K27 三甲基化是早期的表观遗传事件。
Nutrients. 2024 Sep 26;16(19):3260. doi: 10.3390/nu16193260.
5
Upregulation of Enhancer of Zeste Homolog 2 (EZH2) with Associated pERK Co-Expression and PRC2 Complex Protein SUZ12 Correlation in Adult T-Cell Leukemia/Lymphoma.成年T细胞白血病/淋巴瘤中zeste同源物2（EZH2）增强子上调与相关pERK共表达及PRC2复合物蛋白SUZ12的相关性
Cancers (Basel). 2024 Feb 2;16(3):646. doi: 10.3390/cancers16030646.
6
EZH2 synergizes with BRD4-NUT to drive NUT carcinoma growth through silencing of key tumor suppressor genes.EZH2与BRD4-NUT协同作用，通过沉默关键肿瘤抑制基因来驱动NUT癌生长。
bioRxiv. 2023 Aug 16:2023.08.15.553204. doi: 10.1101/2023.08.15.553204.
7
Establishment of Organoids From Human Epithelioid Sarcoma With the Air-Liquid Interface Organoid Cultures.通过气液界面类器官培养从人上皮样肉瘤建立类器官
Front Oncol. 2022 May 23;12:893592. doi: 10.3389/fonc.2022.893592. eCollection 2022.
8
Whole-genome and transcriptome analysis of advanced adrenocortical cancer highlights multiple alterations affecting epigenome and DNA repair pathways.高级肾上腺皮质癌的全基因组和转录组分析强调了多个影响表观基因组和 DNA 修复途径的改变。
Cold Spring Harb Mol Case Stud. 2022 Apr 28;8(3). doi: 10.1101/mcs.a006148. Print 2022 Apr.
9
A Chemical Strategy toward Novel Brain-Penetrant EZH2 Inhibitors.一种针对新型脑渗透性EZH2抑制剂的化学策略。
ACS Med Chem Lett. 2022 Feb 10;13(3):377-387. doi: 10.1021/acsmedchemlett.1c00448. eCollection 2022 Mar 10.
10
Toward a Personalized Therapy in Soft-Tissue Sarcomas: State of the Art and Future Directions.软组织肉瘤的个性化治疗：现状与未来方向
Cancers (Basel). 2021 May 13;13(10):2359. doi: 10.3390/cancers13102359.